Atlas Trials

[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer

Clinical trial NCT05936658 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05936658
Sponsor
FutureChem
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
High Risk Prostate Carcinoma
Start date
2023-05-08
Primary completion
2025-06-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.